New Seizure Medication Receives FDA Nod

by Kathy Jones on  November 9, 2013 at 11:40 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

The US Food and Drug Administration confirmed that it has approved Sunovion Pharmaceuticals' Aptiom drug for treating people who are suffering from seizures associated with epilepsy.
 New Seizure Medication Receives FDA Nod
New Seizure Medication Receives FDA Nod

The FDA said that the drug has been approved for treating 'partial seizures', usually seen in epilepsy patients, after results of three clinical trials showed it to be effective in reducing frequency of seizures among epilepsy patients.

The drug though has the same side-effects as other anti-seizure drugs, with symptoms ranging from headache, nausea, drowsiness, dizziness, double-vision, vomiting, and fatigue, while it was also found to increase suicidal thoughts among a small number of patients.

"Some patients with epilepsy do not achieve satisfactory seizure control from existing treatments. It is important we continue to make new treatment options available to patients", Dr Eric Bastings from FDA's Center for Drug Evaluation and Research said.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Epilepsy Febrile Fits / Febrile Convulsions Healthy Living Convulsions Absence Seizure 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive